108 related articles for article (PubMed ID: 35395987)
1. [Changes of Serum Complement C1q in Patients with Multiple Myeloma].
Gui CS; Liu SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):506-510. PubMed ID: 35395987
[TBL] [Abstract][Full Text] [Related]
2. Is complement C1q a potential marker for tumor burden and immunodeficiency in multiple myeloma?
Yang R; Huang J; Ma H; Li S; Gao X; Liu Y; Shen J; Liao A
Leuk Lymphoma; 2019 Jul; 60(7):1812-1818. PubMed ID: 30628497
[TBL] [Abstract][Full Text] [Related]
3. Expression of C1q in the serum of patients with non‑severe aplastic anemia, and its association with disease severity.
Ding S; Liu C; Li Y; Liu H; Liu Z; Chen T; Zhang T; Shao Z; Fu R
Mol Med Rep; 2019 Feb; 19(2):1194-1202. PubMed ID: 30569170
[TBL] [Abstract][Full Text] [Related]
4. [Predictive Value of Newly Diagnosed IgG Level in Patients with IgG-type Multiple Myeloma after Initial Treatment].
Li Q; Hu CD; Zhang CC; Jiang W; Wang QR; Sun YC; Yang JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1825-1830. PubMed ID: 34893118
[TBL] [Abstract][Full Text] [Related]
5. [Expression and Clinical Significance of MMSA-8 and MMSA-1 in Bone Marrow of Patients with M2 Acute Myeloid Leukemia].
Liang Y; Yang AY; Liu M; Cheng YJ; Zang SB; Huang J; Tang YY; Huang ZP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1018-1021. PubMed ID: 35981356
[TBL] [Abstract][Full Text] [Related]
6. [The Influence of Serum Homocysteine Level to the Prognosis of Newly Diagnosed Multiple Myeloma Patients and Analysis of Related Factors].
Fu Y; Wei XF; Feng YF; Liu F; Chen QL; Zhao YY; Zhang WJ; Ma T; Huang XJ; Chen Y; Li QF; Zhang QK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):530-534. PubMed ID: 33812426
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of bone disease in multiple myeloma and clinical significance of monitoring bone metabolic markers].
Chu B; Lu MQ; Wu MQ; Shi L; Fu LN; Gao S; Fang LJ; Xiang QQ; Bao L
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1424-9. PubMed ID: 27266350
[TBL] [Abstract][Full Text] [Related]
8. Serum complement C1q level is associated with acute coronary syndrome.
Ni XN; Yan SB; Zhang K; Sai WW; Zhang QY; Ti Y; Wang ZH; Zhang W; Zheng CY; Zhong M
Mol Immunol; 2020 Apr; 120():130-135. PubMed ID: 32120180
[TBL] [Abstract][Full Text] [Related]
9. Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma.
Xu J; Sun Y; Jiang J; Xu Z; Li J; Xu T; Liu P
Front Immunol; 2020; 11():1292. PubMed ID: 32760394
[TBL] [Abstract][Full Text] [Related]
10. A Preliminary Study of the Complement Component 1q Levels in Predicting the Efficacy of Combined Immunotherapy in Patients with Lung Cancer.
Zhang D; Li Y; Li H; Tang T; Zheng Y; Guo X; Xu X
Cancer Manag Res; 2021; 13():7131-7137. PubMed ID: 34531687
[TBL] [Abstract][Full Text] [Related]
11. Increased serum levels of complement C1q in major depressive disorder.
Yao Q; Li Y
J Psychosom Res; 2020 Jun; 133():110105. PubMed ID: 32272297
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
13. [Clinical Characteristics and Prognosis of Multiple Myeloma Patients with Different Results of Blood Separation].
Zhang JY; Fan H; Zhang J; Zhao Q; Xu D; You FF; Guo L; Zhang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):547-552. PubMed ID: 32319394
[TBL] [Abstract][Full Text] [Related]
14. Study on the Relationship Between the Expression of B Cell Mature Antigen and the Classification, Stage, and Prognostic Factors of Multiple Myeloma.
Ma T; Shi J; Xiao Y; Bian T; Wang J; Hui L; Wang M; Liu H
Front Immunol; 2021; 12():724411. PubMed ID: 34867949
[TBL] [Abstract][Full Text] [Related]
15. [The roles of serum free light chain ratio in the diagnosis and prognosis of newly diagnosed multiple myeloma].
Wang PF; Xu Y; Yan S; Yao Y; Zheng HF; Ma L; Jin S; Xu Y; Gong FR; Zhou JZ; Chang HR; Fu CC
Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):377-82. PubMed ID: 27210871
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic Value of Corrected Levels of Serum Calcium and Serum Lactate Dehydrogenase for Newly Diagnosed Multiple Myeloma Patients].
Xie YM; Cui YJ; Li H; Pan XR; Xu YX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):844-849. PubMed ID: 31204942
[TBL] [Abstract][Full Text] [Related]
17. [BAFF level in bone marrow and expression of BAFF receptor on B cells in multiple myeloma patients].
Zhou ZH; Zhang L; Pan QY; Huang BH; Zheng D; Liu JR; Li J; Luo SK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1131-4. PubMed ID: 23114133
[TBL] [Abstract][Full Text] [Related]
18. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
[TBL] [Abstract][Full Text] [Related]
19. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
20. The Value of Serum Complement C1q in the Diagnosis of Acute Ischemic Stroke.
Zhao X; Wang C; Pang B; Zhu Y; Zhang Y
Clin Lab; 2017 May; 63(5):915-920. PubMed ID: 28627821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
